| Year |
Citation |
Score |
| 2022 |
Padula L, Fisher E, Rivas K, Podack K, Frasca D, Kupritz J, Seavey MM, Jayaraman P, Dixon E, Jasuja R, Strbo N. Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses. Vaccine: X. 12: 100202. PMID 35936992 DOI: 10.1016/j.jvacx.2022.100202 |
0.38 |
|
| 2020 |
Fisher E, Padula L, Podack K, O'Neill K, Seavey MM, Jayaraman P, Jasuja R, Strbo N. Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice. Frontiers in Immunology. 11: 602254. PMID 33584668 DOI: 10.3389/fimmu.2020.602254 |
0.363 |
|
| 2019 |
Hutchins J, Tahiliani V, Miriyala J, Rose J, Dillon P, Seavey MM. Effect on anti-tumor immunity and long-term memory CD8+ T-cell generation with a novel, allogeneic cell-based, Gp96-Ig/OX40L cancer vaccine. Journal of Clinical Oncology. 37: e14016-e14016. DOI: 10.1200/JCO.2019.37.15_SUPPL.E14016 |
0.389 |
|
| 2012 |
Seavey MM, Lu LD, Stump KL, Wallace NH, Hockeimer W, O'Kane TM, Ruggeri BA, Dobrzanski P. Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer. Molecular Cancer Therapeutics. 11: 984-93. PMID 22334590 DOI: 10.1158/1535-7163.Mct-11-0951 |
0.343 |
|
| 2012 |
Seavey MM, Lu LD, Stump KL, Wallace NH, Ruggeri BA. Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE. International Immunopharmacology. 12: 257-70. PMID 22178195 DOI: 10.1016/J.Intimp.2011.11.019 |
0.319 |
|
| 2012 |
Wood LM, Pan ZK, Seavey MM, Muthukumaran G, Paterson Y. The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii. 61: 689-700. PMID 22057675 DOI: 10.1007/S00262-011-1129-9 |
0.391 |
|
| 2011 |
Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2. Journal of Immunology (Baltimore, Md. : 1950). 187: 3840-53. PMID 21880982 DOI: 10.4049/Jimmunol.1101228 |
0.356 |
|
| 2011 |
Wood LM, Pan ZK, Guirnalda P, Tsai P, Seavey M, Paterson Y. Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105. Cancer Immunology, Immunotherapy : Cii. 60: 931-42. PMID 21431419 DOI: 10.1007/S00262-011-1002-X |
0.421 |
|
| 2011 |
Shahabi V, Seavey MM, Maciag PC, Rivera S, Wallecha A. Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human. Cancer Gene Therapy. 18: 53-62. PMID 20725099 DOI: 10.1038/Cgt.2010.48 |
0.485 |
|
| 2009 |
Seavey MM, Mosmann TR. Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization. Vaccine. 27: 2342-9. PMID 19428849 DOI: 10.1016/J.Vaccine.2009.02.025 |
0.582 |
|
| 2009 |
Seavey MM, Maciag PC, Al-Rawi N, Sewell D, Paterson Y. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model. Journal of Immunology (Baltimore, Md. : 1950). 182: 5537-46. PMID 19380802 DOI: 10.4049/Jimmunol.0803742 |
0.39 |
|
| 2009 |
Seavey MM, Pan ZK, Maciag PC, Wallecha A, Rivera S, Paterson Y, Shahabi V. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 924-32. PMID 19188163 DOI: 10.1158/1078-0432.Ccr-08-2283 |
0.391 |
|
| 2008 |
Wood LM, Guirnalda PD, Seavey MM, Paterson Y. Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. Immunologic Research. 42: 233-45. PMID 19018479 DOI: 10.1007/S12026-008-8087-0 |
0.451 |
|
| 2008 |
Maciag PC, Seavey MM, Pan ZK, Ferrone S, Paterson Y. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Research. 68: 8066-75. PMID 18829565 DOI: 10.1158/0008-5472.Can-08-0287 |
0.479 |
|
| 2008 |
Seavey MM, Mosmann TR. Immunoregulation of fetal and anti-paternal immune responses. Immunologic Research. 40: 97-113. PMID 18213524 DOI: 10.1007/S12026-007-8005-X |
0.519 |
|
| 2006 |
Seavey MM, Mosmann TR. Paternal antigen-bearing cells transferred during insemination do not stimulate anti-paternal CD8+ T cells: role of estradiol in locally inhibiting CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 177: 7567-78. PMID 17114426 DOI: 10.4049/Jimmunol.177.11.7567 |
0.559 |
|
| Show low-probability matches. |